Toxicology in the fast lane: Application of high-throughput bioassays to detect modulation of key enzymes and receptors

Environmental Health Perspectives

Volumn 117, Issue 12, 2009, Pages 1867-1872

  Morisseau, Christophe ^a   Merzlikin, Oleg ^a   Lin, Amy ^a   He, Guochun ^a   Feng, Wei ^a   Padilla, Isela ^a   Denison, Michael S ^a   Pessah, Isaac N ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioassays; Biomarkers; Enzyme inhibition; High throughput assays; Triclocarban; Triclosan

Indexed keywords

CARBOXYLESTERASE; ENZYME; FUNGICIDE; RECEPTOR; RYANODINE RECEPTOR; TRICLOSAN;

ARTICLE; BIOASSAY; FEASIBILITY STUDY; HIGH THROUGHPUT SCREENING; MEDICAL INFORMATION; PRIORITY JOURNAL; RELIABILITY; SYNTHESIS; TOXICOLOGY;

ANIMALS; CARBOXYLESTERASE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NAPHTHOQUINONES; RECEPTORS, ANDROGEN; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TOXICOLOGY; TRICLOSAN;

ANIMALIA;

EID: 75349100795     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900834     Document Type: Article

References (51)

1. Ahn KC, Zhao B, Chen J, Cherednichenko G, Sanmarti E, Denison MS, et al. 2008. In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect 16:1203-1210.
2. Beetham JK, Tian T, Hammock BD. 1993. cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch Biochem Biophys 305:197-201.
3. Bellinger AM, Mongillo M, Marks AR. 2008. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J Clin Invest 118:445-453.
4. Berridge MJ. 2006. Calcium microdomains: organization and function. Cell Calcium 40:405-412.
5. Bonefeld-Jørgensen EC, Long M, Hofmeister MV, Vinggaard AM. 2007. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-noctylphenol in vitro: new data and a brief review. Environ Health Perspect 115(suppl 1):69-76.
6. Cali JJ, Ma D, Sobol M, Simpson DJ, Frackman S, Good TD, et al. 2006. Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol 2:629-645.
7. California Department of Toxic Substances Control. 2008. California Green Chemistry Initiative Final Report. Available: http://www.dtsc.ca.gov/ PollutionPrevention/GreenChemistryInitiative/upload/GREEN-Chem.pdf [accessed 8 June 2009].
8. Casida JE, Quistad GB. 2005. Serine hydrolase targets of organophosphorus toxicants. Chem Biol Interact 157-158:277-283.
9. Chen CW, Hurd C, Vorojeikina DP, Arnold SF, Notides AC. 1997. Transcriptional activitation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem Pharmacol 53:1161-1172.
10. Denison MS, Heath-Pagliuso S. 1998. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull Environ Contam Toxicol 61: 557-568.
11. Denison MS, Nagy SR. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 43: 309-334.
12. Dixon M. 1972. Graphical determination of Km and Ki. Biochem J 129:197-202.
13. Dutton DR, Parkinson A. 1989. Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Arch Biochem Biophys 268:617-629.
14. European Chemicals Agency. 2007. REACH: Registration, Evaluation, Authorisation and Restriction of Chemicals. Available: http://echa.europa.eu/ reach-en.asp [accessed 8 June 2009].
15. Feng W, Liu G, Xia R, Abramson JJ, Pessah IN. 1999. Site-selective modification of hyperreactive cysteines of ryanodine receptor complex by quinones. Mol Pharmacol 55:821-831.
16. Gad SC. 2006. Introduction. In: Animal Models in Toxicology, 2nd ed (Gad SC, ed). New York:Informa HealthCare, 1-18.
17. Garrison PM, Tullis K, Aarts JM, Brouwer A, Giesy JP, Denison MS. 1996. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetra chloro dibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol 30:194-203.
18. Gibb S. 2008. Toxicity testing in the 21st century: a vision and a strategy. Reprod Toxicol 25:136-138.
19. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
20. Han D, Nagy SR, Denison MS. 2004. Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. Biofactors 20:11-22.
21. Harada T, Nakagawa Y, Wadkins RM, Potter PM, Wheelock CE. 2009. Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis. Bioorg Med Chem 17:149-164.
22. Huang H, Nishi K, Tsai H-J, Hammock BD. 2007. Development of highly sensitive fluorescent assays for fatty acid amide hydrolase. Anal Biochem 363:12-21.
23. James RW. 2006. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 44:1052-1059.
24. Jones PD, Wolf NM, Morisseau C, Whetstone P, Hock B, Hammock BD. 2005. Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Anal Biochem 343:66-75.
25. Kärenlampi SO, Tuomi K, Korkalainen M, Raunio H. 1989. 2-(4′-Chlorophenyl)benzothiazole is a potent inducer of cytochrome P450IA1 in a human and a mouse cell line. Anomalous correlation between protein and mRNA induction. Eur J Biochem 181:143-148.
26. Kenet T, Froemcke R, Schreiner C, Pessah IN, Merzenich MM. 2007. Abnormal auditory cortex development in PCB exposed rats. Proc Natl Acad Sci USA 104:7646-7651.
27. Kim KH, Inan SY, Berman RF, Pessah IN. 2009. Differential patterns of excitotoxicity and ryanodine receptor modulation in the hippocampus by two ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol 237:168-177.
28. Maranghi F, Rescia M, Macri C, Di Consiglio E, De Angelis G, Testai E, et al. 2007. Lindane may modulate the female reproductive development through the interaction with ER-β: an in vivo-in vitro approach. Chem Biol Interact 169:1-14.
29. McGovern SL, Caselli E, Grigorieff N, Shoichet BK. 2002. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45:1712-1722.
30. Morisseau C, Goodrow MH, Dowdy D, Zheng J, Greene JF, Sanborn JR, et al. 1999. Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci USA 96:8849-8854.
31. Morisseau C, Hammock BD. 2008. Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical. Pest Manag Sci 64:594-609.
32. Nagy SR, Sanborn JR, Hammock BD, Denison MS. 2002. Development of a green fluorescent protein based cell bioassay for the rapid and inexpensive detection and characterization of AhR agonists. Toxicol Sci 65:200-210.
33. National Center for Biotechnology Information. 2009. PubChem. Available: http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=707 [accessed 3 November 2009].
34. Nishi K, Huang H, Kamita SG, Kim I-H, Morisseau C, Hammock BD. 2006. Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. Arch Biochem Biophys 445:115-123.
35. Owens CV Jr, Lambright C, Bobseine K, Ryan B, Gray LE Jr, Gullett BK, et al. 2007. Identification of estrogenic compounds emitted from the combustion of computer printed circuit boards in electronic waste. Environ Sci Technol 41:8506-8511.
36. 2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol Pharmacol 37:503-514.
37. 2+, caffeine, and adenine nucleotides. Mol Pharmacol 31:232-238.
38. Roegge CS, Morris JR, Villareal S, Wang VC, Powers BE, Klintsova AY, et al. 2006. Purkinje cell and cerebellar effects following developmental exposure to PCBs and/or MeHg. Neurotoxicol Teratol 28:74-85.
39. Rogers JM, Denison MS. 2000. Recombinant cell bioassay for endocrine disruptors: development of stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. In Vitr Mol Toxicol 3:67-82.
40. Saito A, Seiler S, Chu A, Fleischer S. 1984. Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 99:875-885.
41. Satoh T, Hosokawa M. 2006. Structure, function and regulation of carboxylesterases. Chem Biol Interact 162:195-211.
42. Scialli AR. 2008. The challenge of reproductive and developmental toxicology under REACH. Regul Toxicol Pharmacol 51:244-250.
43. Shan G, Hammock BD. 2001. Development of sensitive esterase assays based on alpha-cyano-containing esters. Anal Biochem 299:54-62.
44. Silliman CC, Wang M. 2006. The merits of in vitro versus in vivo modeling in investigation of the immune system. Environ Toxicol Pharmacol 21:123-134.
45. Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, et al. 1996. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Cancer Res 56:5403-5409.
46. Tingle MD, Helsby NA. 2006. Can in vitro drug metabolism studies with human tissue replace in vivo animal studies? Environ Toxicol Pharmacol 21:184-190.
47. U.S. Environmental Protection Agency. 1998. High Production Volume (HPV) Challenge Program. Available: http://www. epa.gov/HPV/ [accessed 8 June 2009].
48. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30:75-95.
49. Wixtrom RN, Silva MH, Hammock BD. 1988. Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels. Anal Biochem 169:71-80.
50. Yang D, Kim KH, Phimister A, Bachstetter A, Ward T, Stackman R, et al. 2009. Developmental exposure to polychlorinated biphenyls (PCBs) interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect 117:426-435.
51. Zhang J, Chung TDY, Oldenburg KR. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73.